Insider Activity of ALTSHULER DAVID
Biography of ALTSHULER DAVID
No biography is available at this moment.
No biography is available at this moment.
| 2025-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 52 <0.0001% | $424.69 | $22,084 | +2.08% | |
| 2025-03-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 3,231 0.0013% | $510.00 | $1.65M | -10.52% | |
| 2025-03-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 3,231 0.0013% | $500.00 | $1.62M | -10% | |
| 2025-03-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 3,231 0.0013% | $490.00 | $1.58M | -6.89% | |
| 2025-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 1,272 0.0005% | $480.00 | $610,560 | -5.16% | |
| 2025-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 848 0.0003% | $480.95 | $407,846 | -6.31% | |
| 2025-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 1,111 0.0004% | $480.00 | $533,280 | -6.31% | |
| 2024-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 15 <0.0001% | $478.56 | $7,178 | -4.23% | |
| 2024-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 54 <0.0001% | $430.93 | $23,270 | +8.47% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,239 0.0016% | $425.70 | $1.8M | +7.29% | |
| 2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 3,002 0.0012% | $421.77 | $1.27M | +10.7% | |
| 2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,002 0.0016% | $420.79 | $1.68M | +10.34% | |
| 2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 3,145 0.0012% | $420.24 | $1.32M | +10.8% | |
| 2023-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 19 <0.0001% | $369.92 | $7,028 | +26.67% | |
| 2023-08-09 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 63 <0.0001% | $345.51 | $21,767 | +18.92% | |
| 2023-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,238 0.0016% | $287.51 | $1.22M | +21.83% | |
| 2023-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,002 0.0016% | $293.77 | $1.18M | +19.59% | |
| 2023-02-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 6,398 0.0025% | $298.70 | $1.91M | +16.37% | |
| 2023-02-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,798 0.0019% | $298.90 | $1.43M | +16.78% | |
| 2023-02-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 153 <0.0001% | $309.06 | $47,286 | +14.36% |